Margaret Kyle
Overview
Explore the profile of Margaret Kyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Firestein M, Manessis A, Warmingham J, Xu R, Hu Y, Finkel M, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2435005.
PMID: 39312236
Importance: Stress and viral illness during pregnancy are associated with neurodevelopmental conditions in offspring. Autism screening positivity for children born during the pandemic remains unknown. Objective: To examine associations between...
2.
Firestein M, Shuffrey L, Hu Y, Kyle M, Hussain M, Bianco C, et al.
JAMA Netw Open
. 2023 Apr;
6(4):e237396.
PMID: 37036706
Importance: Associations between prenatal SARS-CoV-2 exposure and neurodevelopmental outcomes have substantial public health relevance. A previous study found no association between prenatal SARS-CoV-2 infection and parent-reported infant neurodevelopmental outcomes, but...
3.
Costinot A, Donaldson D, Kyle M, Williams H
Q J Econ
. 2019 Apr;
134(2):843-894.
PMID: 30983637
The home-market effect, first hypothesized by Linder (1961) and later formalized by Krugman (1980), is the idea that countries with larger demand for some products at home tend to have...
4.
5.
Grabowski H, Kyle M, Mortimer R, Long G, Kirson N
Health Aff (Millwood)
. 2011 Nov;
30(11):2157-66.
PMID: 22068409
The evolution of pharmaceutical competition since Congress passed the Hatch-Waxman Act in 1984 raises questions about whether the act's intended balance of incentives for cost savings and continued innovation has...
6.
Barnighausen T, Kyle M, Salomon J, Waning B
Health Policy Plan
. 2011 Sep;
27(6):467-76.
PMID: 21914713
Despite extraordinary global progress in increasing coverage of antiretroviral treatment (ART), the majority of people needing ART currently are not receiving treatment. Both the number of people needing ART and...
7.
Waning B, Kyle M, Diedrichsen E, Soucy L, Hochstadt J, Barnighausen T, et al.
Global Health
. 2010 May;
6:9.
PMID: 20500827
Background: Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited...